When analyzing the DFS, high expression of LRP11 was associated with a worse prognosis in ACC (HR:1.9; 95% CI; Logrank-p = 0.049), CESC (HR:2.6; 95% CI; Logrank-p = 0.0024), and LIHC (HR:1.9; 95% CI; Logrank-p<0.0001), while low expression of LRP11 indicated better prognosis in KIRC (HR:0.62; 95% CI; Logrank-p = 0.01) (Figure 1B lower panel and Supplementary Table S1). The gene discussed is LRP11; the disease is adrenal cortex carcinoma.